9C7D image
Entry Detail
PDB ID:
9C7D
Keywords:
Title:
Human monoclonal antibody MAD22-38 bound to the N-terminus of cleaved circumsporozoite protein
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2024-06-10
Release Date:
2024-12-25
Method Details:
Experimental Method:
Resolution:
1.99 Å
R-Value Free:
0.23
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Circumsporozoite protein
Chain IDs:C (auth: B)
Chain Length:18
Number of Molecules:1
Biological Source:Plasmodium falciparum 3D7
Polymer Type:polypeptide(L)
Description:Monoclonal antibody MAD22-38 Fab Heavy Chain
Chain IDs:A (auth: H)
Chain Length:227
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Monoclonal antibody MAD22-38 Fab Light Chain
Chain IDs:B (auth: L)
Chain Length:213
Number of Molecules:1
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
PCA C GLN modified residue
Primary Citation

Abstact

The most advanced monoclonal antibodies (mAbs) and vaccines against malaria target the central repeat region or closely related sequences within the Plasmodium falciparum circumsporozoite protein (PfCSP). Here, using an antigen-agnostic strategy to investigate human antibody responses to whole sporozoites, we identified a class of mAbs that target a cryptic PfCSP epitope that is only exposed after cleavage and subsequent pyroglutamylation (pGlu) of the newly formed N terminus. This pGlu-CSP epitope is not targeted by current anti-PfCSP mAbs and is not included in the licensed malaria vaccines. MAD21-101, the most potent mAb in this class, confers sterile protection against Pf infection in a human liver-chimeric mouse model. These findings reveal a site of vulnerability on the sporozoite surface that can be targeted by next-generation antimalarial interventions.

Legend

Protein

Chemical

Disease

Primary Citation of related structures